Immediate Impact
13 by Nobel laureates 24 from Science/Nature 113 standout
Citing Papers
Outcomes after Critical Illness
2023 Standout
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
2022 Standout
Works of Jacquelyn Burkell being referenced
What are the chances? Evaluating risk and benefit information in consumer health materials.
2004
The dilemma of survey nonresponse
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jacquelyn Burkell | 777 | 367 | 29 | 910 | 81 | 2.6k | |
| Eric Loken | 778 | 228 | 3 | 520 | 66 | 4.1k | |
| Keenan A. Pituch | 381 | 160 | 4 | 551 | 74 | 2.6k | |
| Stefan Stieger | 2021 | 369 | 6 | 734 | 134 | 4.0k | |
| Susanne E. Baumgartner | 1259 | 351 | 1 | 251 | 68 | 2.5k | |
| René Riedl | 781 | 134 | 2 | 460 | 119 | 2.6k | |
| L. Mark Carrier | 1809 | 347 | 2 | 800 | 21 | 3.3k | |
| John C. Shaw | 585 | 76 | 3 | 942 | 55 | 3.6k | |
| Leib Litman | 1165 | 117 | 13 | 633 | 30 | 2.9k | |
| Kai Kaspar | 442 | 79 | 1 | 528 | 89 | 1.8k | |
| Leslie K. John | 1271 | 117 | 26 | 266 | 60 | 4.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...